Results 51 to 60 of about 96,342 (294)

Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. [PDF]

PLoS ONE, 2013
ObjectivesTo evaluate therapy for Mycoplasma genitalium infection with doxycycline or azithromycin 1 g compared to five days of azithromycin (total dose 1.5 g).MethodsA retrospective case study was performed among patients attending the STD-clinic in ...
Carin Anagrius, Britta Loré, Jørgen Skov Jensen   +2 more
doaj   +1 more source

Azithromycin and the Outcome of Treated COVID-19 Patients: A Hospital-Based Study

Journal of Midwifery, 2022
COVID-19 is an infectious disease that has been declared a pandemic. Currently, there is no validated pharmacological treatment for use in COVID-19 disease and is still in the clinical trial stage.
Elly Usman
doaj   +1 more source

Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis.

New England Journal of Medicine, 2021
BACKGROUND Rectal chlamydia is a common bacterial sexually transmissible infection among men who have sex with men. Data from randomized, controlled trials are needed to guide treatment.
Andrew Lau, F. Kong, C. Fairley, D. Templeton, J. Amin, S. Phillips, M. Law, Marcus Y. Chen, C. Bradshaw, B. Donovan, A. McNulty, M. Boyd, P. Timms, E. Chow, D. Regan, C. Khaw, D. Lewis, J. Kaldor, M. Ratnayake, N. Carvalho, J. Hocking   +20 more
semanticscholar   +1 more source

Azithromycin Prevents Pregnancy Loss: Reducing the Level of Tumor Necrosis Factor-Alpha and Raising the Level of Interleukin-10 in Rats

Mediators of Inflammation, 2013
The aim of this study was to determine the effect of azithromycin on LPS-induced pregnancy loss. Thirty-six pregnant female Wistar rats were divided into 4 equal groups as follows: control group, where 0.3 mL of normal saline solution was administered ...
Ayse Er
doaj   +1 more source

Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients

medRxiv, 2020
Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this novel infection.
P. Carlucci, Tania Ahuja, Christopher Petrilli, Harish Rajagopalan, Simon Jones, Joseph Rahimian   +5 more
semanticscholar   +1 more source

Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial

Malaria Journal, 2021
Background Azithromycin has recently been shown to reduce all-cause childhood mortality in sub-Saharan Africa. One potential mechanism of this effect is via the anti-malarial effect of azithromycin, which may help treat or prevent malaria infection. This
Boubacar Coulibaly, Ali Sié, Clarisse Dah, Mamadou Bountogo, Mamadou Ouattara, Adama Compaoré, Moustapha Nikiema, Jérôme Nankoné Tiansi, Nestor Dembélé Sibiri, Jessica M. Brogdon, Elodie Lebas, Thuy Doan, Travis C. Porco, Thomas M. Lietman, Catherine E. Oldenburg   +14 more
doaj   +1 more source

Periodontal microbiology and microbial etiology of periodontal diseases: Historical concepts and contemporary perspectives

Periodontology 2000, EarlyView., 2023
Abstract This narrative review summarizes the collective knowledge on periodontal microbiology, through a historical timeline that highlights the European contribution in the global field. The etiological concepts on periodontal disease culminate to the ecological plaque hypothesis and its dysbiosis‐centered interpretation.
Georgios N. Belibasakis, Daniel Belstrøm, Sigrun Eick, Ulvi K. Gursoy, Anders Johansson, Eija Könönen   +5 more
wiley   +1 more source

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2020
Background Despite a lack of clinical evidence, hydroxychloroquine and azithromycin are being administered widely to patients with verified or suspected coronavirus disease 2019 (COVID‐19).
A. Ramireddy, H. Chugh, K. Reinier, J. Ebinger, E. Park, M. Thompson, E. Cingolani, Susan Cheng, E. Marbán, C. Albert, S. Chugh   +10 more
semanticscholar   +1 more source

Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis

Periodontology 2000, EarlyView., 2023
Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera, Arie Jan van Winkelhoff, Paula Matesanz, Katalina Lauwens, Wim Teughels   +4 more
wiley   +1 more source

Nanomotion technology for testing azithromycin susceptibility of Salmonella enterica

Microbiology Spectrum
Invasive salmonellosis caused by Salmonella enterica subspecies affects millions of people every year, mostly children from low-income countries, and is associated with a high mortality rate. Azithromycin is used to treat invasive salmonellosis resistant
Mariliis Hinnu, Toomas Mets, Ivana Kerkez, Marta Putrinš, Niilo Kaldalu, Gino Cathomen, Marta Pla Verge, Danuta Cichocka, Alexander Sturm, Tanel Tenson   +9 more
doaj   +1 more source